Sientra, inc. (SIEN)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Cash flows from operating activities:
Net loss

-106,818

-82,627

-64,028

-40,166

-

-

-

-

Net loss

-

-

-

-

-41,230

-5,811

-19,125

-23,433

Adjustments to reconcile net loss to net cash used in operating activities
Goodwill impairment

7,629

0

0

-

14,278

-

-

-

Intangible asset impairment

5,045

0

0

-

-

-

-

-

Depreciation and amortization

3,524

3,321

3,034

1,177

318

275

280

288

Provision for doubtful accounts

2,298

2,043

493

437

233

39

107

140

Provision for sales return reserve

-

-

-

-

-

-

-

4,240

Provision for warranties

929

325

294

71

385

447

392

123

Provision for inventory

2,626

955

3,125

1,323

469

-

-

-

Amortization of acquired inventory step-up

-

-

-

61

-

-

-

-

Change in fair value of warrants

-75

-81

95

39

-360

220

46

-

Change in fair value of deferred consideration

100

24

-110

37

-

-

-

-

Change in fair value of contingent consideration

1,044

2,528

1,135

-

-

-

-

-

Change in deferred revenue

1,124

627

-

-

-

-

-

-

Non-cash portion of debt extinguishment loss

-53

-

-17

-

-

-

-

-

Amortization of debt discount and issuance costs

359

174

140

-

-

-

-

-

Non-cash interest expense

-

-

-

3

1,386

490

179

-

Stock-based compensation expense

12,478

13,824

6,766

3,236

2,382

594

342

357

Loss on disposal of property and equipment

-119

-74

-25

-124

-

-

-

-

Deferred income taxes

18

-8

-21

61

-

-

-

-

Payments of contingent consideration liability in excess of acquisition-date fair value

1,968

320

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

7,320

14,094

1,890

-927

-715

-875

2,868

7,636

Inventories

10,921

4,144

-1,526

-2,390

898

-1,359

10,852

7,520

Prepaid expenses, other current assets and other assets

8,513

1,302

-713

529

-147

864

-195

575

Customer deposits

-4,008

-4,513

1,136

3,160

-

-

-

-

Customer deposits

-

-

-

-

874

3,707

3,593

849

Sales return liability

2,068

2,142

-

-

-

-

-

-

Insurance recovery receivable

-

-39

-9,336

9,375

-

-

-

-

Accounts payable

-2,225

8,502

1,290

-564

1,546

-2,266

1,904

390

Accrued and other liabilities

7,795

7,885

3,218

-1,422

1,571

1,385

-70

2,931

Legal settlement payable

-410

-590

-9,900

10,900

-

-

-

-

Net cash used in operating activities

-87,033

-56,190

-45,878

-34,430

-

-

-

-

Cash flows from investing activities:
Net cash used in operating activities

-

-

-

-

-18,184

450

-25,877

-29,846

Purchase of property and equipment

4,071

855

1,864

1,126

1,128

439

71

394

Business acquisitions, net of cash and restricted cash acquired

17,943

-

18,150

11,709

-

-

-

-

Net cash used in investing activities

-22,014

-855

-20,014

-12,835

-

-

-

-

Cash flows from financing activities:
Contingent payment related to Silimed acquisition

-

-

-

-

-

-

18,000

-

Net cash used in investing activities

-

-

-

-

-1,128

-439

-18,071

-394

Proceeds from option exercises and employee stock purchase plan

125

1,149

1,346

923

119

38

10

3

Repurchase of common stock

-

-

-

-

-

-

260

-

Proceeds from issuance of preferred stock, net

-

-

-

-

-

-

-

64,553

Net proceeds from issuance of common stock

107,734

107,551

-

-

62,040

80,213

-

-

Proceeds from issuance of common stock under ESPP

1,216

993

647

753

564

-

-

-

Tax payments related to shares withheld for vested restricted stock units (RSUs)

3,064

1,635

725

-

-

-

-

-

Gross borrowings under the Term Loan

5,000

10,000

25,000

-

-

-

-

-

Gross borrowings under the Term Loan

-

-

-

-

-

10,000

15,000

-

Gross borrowings under the Revolving Loan

22,296

12,109

5,000

-

-

-

-

-

Deferred equity issuance costs, IPO

-

-

-

-

71

3,107

-

-

Deferred equity issuance costs, follow-on offering

-

-

-

-

643

-

-

-

Repayment of the Revolving Loan

15,788

12,109

5,000

-

-

-

-

-

Payments of contingent consideration up to acquisition-date fair value

5,766

680

-

-

-

-

-

-

Repayment of long-term debt

-

-

-

-

-26,625

-

-

-

Deferred financing costs

1,997

22

657

-

-

148

288

-

Net cash provided by financing activities

109,756

117,356

25,611

1,676

-

-

-

-

Net increase in cash, cash equivalents and restricted cash

709

60,311

-40,281

-45,589

-

-

-

-

Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Net cash provided by financing activities

-

-

-

-

35,384

86,996

14,462

64,556

Net decrease in cash and cash equivalents

-

-

-

-

16,072

87,007

-29,486

34,316

Supplemental disclosure of cash flow information:
Interest paid

4,089

3,120

870

96

-

-

-

-

Interest paid

-

-

-

-

1,884

1,577

641

-

Supplemental disclosure of non-cash investing and financing activities:
Property and equipment in accounts payable and accrued liabilities

745

679

1,088

-

-

-

-

-

Accrual for the resolution of contingent payment related to Silimed acquisition

-

-

-

-

-

-

-

18,000

Accrued equity issuance costs

-

-

-

-

-

71

-

-

Property and equipment in accounts payable and accrued liabilities

-

-

-

939

22

44

-

-

Acquisition of business, deferred and contingent consideration obligations at fair value

9,063

-

10,912

1,600

-

-

-

-

Non-cash deferred consideration settlement

-

1,000

-

-

-

-

-

-

Non-cash settlement of assets held for sale in accounts payable

-

2,674

-

-

-

-

-

-

Forgiveness of SVB Loan commitment fee

-

-

750

-

-

-

-

-

Deferred financing costs in accrued liabilities

-

-

6

-

-

-

-

-